Onconic Therapeutics Inc. (KOSDAQ:476060)

Onconic Therapeutics Revenue

Onconic Therapeutics had revenue of 22.98B KRW in the quarter ending March 31, 2026, with 150.64% growth. This brings the company's revenue in the last twelve months to 67.20B, up 196.21% year-over-year. In the year 2025, Onconic Therapeutics had annual revenue of 53.39B with 259.82% growth.

• Revenue (ttm): 67.20B
• Revenue Growth: +196.21%
• P/S Ratio: 10.66
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 716.08B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	53.39B	38.55B	259.82%
Dec 31, 2024	14.84B	-6.22B	-29.53%
Dec 31, 2023	21.06B	20.96B	22,064.25%
Dec 31, 2022	95.00M	35.00M	58.33%
Dec 31, 2021	60.00M	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 6, 2026

Data Sources Report a data error